about
Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerizationConnections matter: channeled hydrogels to improve vascularizationEndothelial Extracellular Vesicles-Promises and ChallengesTransactivation of murine cyclin A by polyomavirus large and small T antigens.Laser photofabrication of cell-containing hydrogel constructs.Molecular and cellular effects of in vitro shockwave treatment on lymphatic endothelial cells.Potential and limitations of microscopy and Raman spectroscopy for live-cell analysis of 3D cell cultures.Vascularization mediated by mesenchymal stem cells from bone marrow and adipose tissue: a comparison.Extracorporeal shock wave therapy in situ - a novel approach to obtain an activated fat graft.Lymphatic Vessels in Regenerative Medicine and Tissue Engineering.Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts.A microarray analysis of two distinct lymphatic endothelial cell populations.Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation.The impact of wavelengths of LED light-therapy on endothelial cells.Endothelial Cell-derived Extracellular Vesicles Size-dependently Exert Procoagulant Activity Detected by Thromboelastometry.Emulating human microcapillaries in a multi-organ-chip platform.Dimethylfumarate inhibits tumor-necrosis-factor-induced CD62E expression in an NF-kappa B-dependent manner.Three specific antigens to isolate endothelial progenitor cells from human liposuction material.Adipose-derived stem cells induce vascular tube formation of outgrowth endothelial cells in a fibrin matrix.Improvement of adipose tissue-derived cells by low-energy extracorporeal shock wave therapy.The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cells.Mechanisms of vasculogenesis in 3D fibrin matrices mediated by the interaction of adipose-derived stem cells and endothelial cells.Human platelet lysate is a feasible candidate to replace fetal calf serum as medium supplement for blood vascular and lymphatic endothelial cells.Regulation of matrilysin expression in endothelium by fibroblast growth factor-2.Recessive primary congenital lymphoedema caused by a VEGFR3 mutation.Fibroblast growth factor-2 induces Lef/Tcf-dependent transcription in human endothelial cells.VEGFR-3 expression is restricted to blood and lymphatic vessels in solid tumors.Correction to: The role of fibrinolysis inhibition in engineered vascular networks derived from endothelial cells and adipose-derived stem cellsFunctional Analysis of FLT4 Mutations Associated with Nonne–Milroy LymphedemaMicrovascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A ComparisonDermal microvascular endothelial cells express the 180-kDa macrophage mannose receptor in situ and in vitroPlatelet endothelial cell adhesion molecule-1 and vascular endothelial cadherin cooperatively regulate fibroblast growth factor-induced modulations of adherens junction functionsIL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cellsA novel coagulation assay incorporating adherent endothelial cells in thromboelastometryEngineering of three-dimensional pre-vascular networks within fibrin hydrogel constructs by microfluidic control over reciprocal cell signalingEvery Breath You Take: Non-invasive Real-Time Oxygen Biosensing in Two- and Three-Dimensional Microfluidic Cell ModelsPurinergic P2Y2 receptors modulate endothelial sprouting
P50
Q24311715-6887EA26-41DD-4B57-A3D8-A39BB22F6EAEQ27025521-6D59484D-CF0F-430A-80CF-B89CBDD74B3CQ33639065-8B648D0D-9EC4-4440-B232-7FDD940CFB4FQ33843350-AC53A293-DEBD-4325-B5A2-0A8E50CD6F76Q34986593-D06DA8FA-FD5D-4084-B13B-0FFD36FA3138Q35515856-A60860EF-4CF5-4DBF-8E5F-38D47197761DQ35562270-10343171-ADF3-4BD7-AF96-26D7023B2822Q38616300-DCDF8C66-553D-4E98-BFA7-871D44BC2DBEQ38685925-7D63D894-D0DE-49E0-8893-C9255EBAAA08Q38824712-F712924D-B1AF-4486-BAD3-E1EEEB42F581Q38957235-70A06F25-4592-428D-8753-83DDF84CF39EQ40411918-41914C96-8DCB-4DC1-9650-93FFF70D12BAQ40942192-3E631B3B-978A-4126-8222-838926B5EFFAQ41629093-90866233-7111-4821-9113-6B842F61104EQ42198519-BF162619-E0BA-4920-9863-BF77544EBB36Q42483251-D0E50F78-894B-4CCD-9CF0-4D6C8137064EQ43910761-673AC747-E2D7-413A-88C1-D98DE7C31379Q44691187-F562255C-BA11-4530-BE57-141045B73577Q45193574-16A48B95-6548-4668-A5BC-8EC91ECA15A5Q47892590-4CC116D3-ADA4-4CA2-8C55-FD08BA403C0BQ49733672-CBA89AFB-7166-4F8F-AE7A-6197B88532AFQ50451844-A2D01A35-161A-465C-8CDC-DBAC4F148631Q50468782-D2FC7031-8672-40B0-91FF-BCFBE876DF9CQ51264184-D460928A-14EC-4777-8C2E-5B2350134012Q51766990-03376570-CA2C-41AB-AC5E-FABDF5E8E916Q52114774-B9C619C7-92DF-492E-8D4F-22722090444DQ54529734-64E1B1D3-6A23-4732-989F-A7BD9C983A1BQ57183114-8AAF4C3A-A313-4147-A054-7876B067BA48Q57381981-17342BF1-065F-4B52-807F-32D924C190E7Q58556028-C2448D7E-50A0-4C57-822B-E5F5353A0CBDQ73163063-C0C34804-7B3C-48C9-AB5F-F74F54FA53B6Q73419472-26697B20-FB38-44C7-A8BF-39B74EC4286CQ81111357-25BC4EBF-04E7-4E60-B2AA-202F23DD6732Q86389600-1564AE62-3DEA-499A-B996-F9060EE484BEQ89464929-303F02A7-4611-4441-A734-4DF49C3D69DBQ90297229-1EDC9842-42D9-4F81-B6FB-E03079BC8E21Q91666775-4A53B67F-80EF-4B0A-BA4E-33472BCDF076
P50
description
researcher ORCID ID = 0000-0001-6425-9028
@en
wetenschapper
@nl
name
Wolfgang Holnthoner
@ast
Wolfgang Holnthoner
@en
Wolfgang Holnthoner
@es
Wolfgang Holnthoner
@nl
type
label
Wolfgang Holnthoner
@ast
Wolfgang Holnthoner
@en
Wolfgang Holnthoner
@es
Wolfgang Holnthoner
@nl
prefLabel
Wolfgang Holnthoner
@ast
Wolfgang Holnthoner
@en
Wolfgang Holnthoner
@es
Wolfgang Holnthoner
@nl
P106
P1153
6506943102
P31
P496
0000-0001-6425-9028